ResearcherSun Yat-sen UniversityActive in the last 2 years
Jiajia Li
Matched on ORCID iD 0009-0005-7848-0897; OpenAlex author ID A5108050456. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 4
- Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-A in pancreatic cancer. Co-author DOI 10.1002/jev2.12484↗
- Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2 mRNA-m6A modification. Co-author DOI 10.1016/j.phrs.2022.106555↗
- Deubiquitinase inhibitor degrasyn suppresses metastasis by targeting USP5-WT1-E-cadherin signalling pathway in pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/jcmm.14813↗
- Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy. Co-author DOI 10.1111/cas.13267↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Guoda Lian · 3 shared papers, 2017–2024 · strength 0.41
- Paper Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-… DOI 10.1002/jev2.12484↗
- Paper Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2… DOI 10.1016/j.phrs.2022.106555↗
- Paper Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy. DOI 10.1111/cas.13267↗
- Yaqing Li · 3 shared papers, 2017–2024 · strength 0.41
- Paper Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-… DOI 10.1002/jev2.12484↗
- Paper Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2… DOI 10.1016/j.phrs.2022.106555↗
- Paper Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy. DOI 10.1111/cas.13267↗
- Kaihong Huang · 3 shared papers, 2017–2024 · strength 0.41
- Paper Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-… DOI 10.1002/jev2.12484↗
- Paper Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2… DOI 10.1016/j.phrs.2022.106555↗
- Paper Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy. DOI 10.1111/cas.13267↗
- Hanming Yao · 2 shared papers, 2023–2024 · strength 0.35
- Paper Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-… DOI 10.1002/jev2.12484↗
- Paper Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2… DOI 10.1016/j.phrs.2022.106555↗
- Shurui Zhou · 2 shared papers, 2023–2024 · strength 0.35
- Paper Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-… DOI 10.1002/jev2.12484↗
- Paper Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2… DOI 10.1016/j.phrs.2022.106555↗
- Jinmao Zou · 2 shared papers, 2023–2024 · strength 0.35
- Paper Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-… DOI 10.1002/jev2.12484↗
- Paper Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2… DOI 10.1016/j.phrs.2022.106555↗
- Kege Yang · 2 shared papers, 2017–2024 · strength 0.25
- Yue Zhao · 1 shared paper, 2024 · strength 0.19
- Ziyi Zhong · 1 shared paper, 2024 · strength 0.19
- Shaojie Chen · 1 shared paper, 2023 · strength 0.16
- Shangxiang Chen · 1 shared paper, 2023 · strength 0.16
- Fengjiao Li · 1 shared paper, 2023 · strength 0.16
- Yue Zhao · 1 shared paper, 2023 · strength 0.16
- Hongwei Sun · 1 shared paper, 2020 · strength 0.11
- Shenmeng Gao · 1 shared paper, 2020 · strength 0.11
- Chumei Huang · 1 shared paper, 2017 · strength 0.06
- Yinting Chen · 1 shared paper, 2017 · strength 0.06
- Linjuan Zeng · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.